Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:00:30.712Z.
Calculation as of: 2026-10-06T21:00:30.712Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 767633254d5919bd59cda52a5696942c7bb29bc9076435c5b91744fa0c767718
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Werewolf Therapeutics, Inc.
Market Cap
$44.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.71M
Operating Cash Flow Yield
11.68%
TTM Avg
4.34%
3Y Avg
2.96%
5Y Avg
2.96%
Market Cap
$44.02M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.83M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.26M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.72M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 11.68% | 4.34% | 2.96% | 2.96% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $42.99M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | N/A | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $46.69M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | N/A | 11.87% | 9.02% | 6.85% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
